Translational Development Acquisition Corp. TDACW
1.15 USD -0.04 (-3.36%)
Nov 4, 2026, 10:22 AM EST
1.05 Day range 1.15
1.05 52-week range 1.15
- YTD
- +9.52%
- 1 year
- +9.52%
Financial health
Altman Z-Score
22.98 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
S-5 / 5 overall
- DCF 5
- Return on Equity 2
- Return on Assets 5
- Debt / Equity 5
- P/E 4
- P/B 5
Valuation
P/E 28.4×
FY 2022 5y median -484× FY 2025
P/S 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 1.0×
FY 2022 5y median -188× FY 2025
P/FCF -297×
FY 2022 5y median -357× FY 2025
EV/EBITDA -192×
FY 2022 5y median -207× FY 2025
EV/Sales 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -0.3%
FY 2022 5y median -0.3% FY 2025
Profitability
Gross Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022 5y median 0.0% FY 2025
ROE 3.6%
FY 2022 5y median 49.6% FY 2025
ROIC -0.5%
FY 2022 5y median -0.3% FY 2025
ROA 3.5%
FY 2022 5y median -8.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2022 FY 2025
Operating Income -381.0%
FY 2022 FY 2025
EPS (diluted) 2384.0%
FY 2022 FY 2025
Free Cash Flow 28.5%
FY 2022 FY 2025
Financial Health
Current Ratio 0.1×
FY 2022 5y median 0.1× FY 2025
Quick Ratio 0.1×
FY 2022 5y median 0.1× FY 2025
Debt / Equity 0.0×
FY 2022 5y median -0.3× FY 2025
Net Debt / EBITDA -0.2×
FY 2022 5y median -0.1× FY 2025
Interest Coverage 0.0×
FY 2022 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31